Dermatological Reviews最新文献

In recent years, the field of dermatology has undergone transformative changes driven by rapid technological advancements. This special issue, titled “New Technologies in Dermatology: Bridging Gaps and Exploring New Frontiers,” reflects the innovative spirit that is redefining clinical practice, research, and education in our specialty. As the guest editor, I am pleased to present a collection of articles that highlight cutting-edge tools and techniques while also exploring their significant implications for patient care and disease management.

The integration of digital imaging, artificial intelligence, teledermatology, and personalized medicine into everyday practice has created huge opportunities for diagnosing, monitoring, and treating skin conditions with greater accuracy and efficiency. Within these pages, you will find contributions from leading experts who examine the technological advances that are bridging longstanding gaps between traditional methodologies and emerging digital solutions. Their insights shed light on how these innovations are addressing challenges such as access to specialized care, early detection of skin cancers, and the management of chronic dermatological disorders.

Furthermore, this issue emphasizes the collaborative nature of modern dermatology. By bringing together perspectives from clinicians, researchers, and technology developers, we highlight a future in which interdisciplinary cooperation drives further breakthroughs. The discussions contained in this issue not only outline the current landscape of technological applications in dermatology but also open the doors for future explorations into uncharted territories.

I invite you to explore the diverse array of articles, and reviews that comprise this issue. Together, they illustrate the dynamic interplay between technology and dermatology, one that holds the promise of improved patient outcomes and a more connected, innovative approach to skin health.

(2024), “Complications After Exosome Treatment for Aesthetic Skin Rejuvenation,” Dermatological Reviews 5: e242, https://doi.org/10.1002/der2.242.

In the article, the errors detailed below were identified. These corrections are due to an earlier version of the manuscript being published without patient consent. These have been corrected in the online version of the article, and they do not affect the overall conclusions.

The second sentence of the Background paragraph originally stated ‘aesthetics purposes in South Korea’. This has been corrected to ‘aesthetics purposes primarily in South Korea, including one patient residing in Australia.’

The second sentence of the Methods paragraph originally read, ‘The case series included eight female patients, ranging in age from 26 to 52 years old’. This has been corrected to “The case series included seven female patients ranging in age from 26 to 37 years old.’

The third paragraph, last sentence originally read ‘aesthetic dermatologists from South Korea’, who observed the complications. This has been corrected to ‘aesthetic dermatologists, who observed the complications. .’

In 2.8 Case 8, the case study was originally stated that, ‘This is a 52-year-old female who developed multiple erythematous papules (pea-sized) on the right cheek in a grid-like pattern (Figure 9), after a month of self-treatment with MTS microneedling and exosomes. These lesions were not painful or pruritic. Six weeks after the exosome self-treatment, she saw another dermatologist and received topical and oral steroids. On presentation to her current dermatologist (2 months after exosome treatment), she had a biopsy of a lesion demonstrating a necrotizing granuloma on H and E staining (Figure 10 A), and an AFB stain of the lesion was also negative (Figure 10B). Blood work involving a complete blood count, smooth muscle antibody, erythrocyte sedimentation rate, and C-reactive protein were within normal limits. Tissue cultures for mycobacteria and atypical mycobacteria were negative. Fungus culture was also negative. Moreover, PCR analysis of the tissue also demonstrated negativity for mycobacteria and atypical mycobacteria. For the first 5 weeks, the patient was given a course of methylprednisolone 8 mg once a day, clarithromycin 500 mg twice a day, and doxycycline 100 mg twice a day.’

This has been replaced by:‘A 29-year-old Chinese female residing in Australia came to South Korea seeking cosmetic treatment, where she received a single exosome treatment administered by a nurse practitioner in August 2023, using a 9-pin multineedle and injection gun. The patient reported that erythematous papules initially appeared at the needle insertion sites approximately 1 month after the treatment and were associated with pruritus. While some lesions resolved spontaneously within the first month after appearance, others persisted and progressively worsened over the next 6 months.’

Two months aft